Literature DB >> 1513194

Influence of cisapride, metoclopramide and loperamide on gastric emptying of normal volunteers as measured by means of the area under the curve of the cumulative fraction absorbed-time profiles of paracetamol.

M van Wyk1, D K Sommers, J Moncrieff.   

Abstract

The present study with paracetamol was designed to compare the effects of 40 mg cisapride, 20 mg metoclopramide and 4 mg loperamide given orally on gastric emptying under fasting conditions in normal volunteers. The well known bioavailability parameters of absorption and the area under the curve of the fractional absorbed time profiles up to 30 min were used as an index of gastric emptying. As reflected by the AUC of the fractional absorbed time profiles, it was concluded that pretreatment with cisapride speeded up the gastric emptying under fasting conditions. Tmax was the only normal bioavailability parameter that showed any significant change after cisapride treatment. Pretreatment with therapeutic doses of loperamide and metoclopramide did not significantly modify stomach emptying.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513194

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  4 in total

1.  Neuronal nitric oxide synthase is necessary for elimination of Giardia lamblia infections in mice.

Authors:  Erqiu Li; Ping Zhou; Steven M Singer
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

2.  Single oral dose of cisapride accelerates gastric antral emptying in healthy humans: an ultrasonographic study.

Authors:  T Takeda; H Konomi; G Naritomi; J Yoshida; H Matsunaga; K Akazawa; M Tanaka
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

3.  Delayed gastric emptying after Billroth I pylorus-preserving pancreatoduodenectomy: effect of postoperative time and cisapride.

Authors:  T Takeda; J Yoshida; M Tanaka; H Matsunaga; K Yamaguchi; K Chijiiwa
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

Review 4.  Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.